SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward a key psychological support level dominates discussion, with traders linking the pressure to a broader crypto selloff, Bitcoin weakness, inflation and rate-hike concerns, and leveraged liquidations. Bears warn of further downside and question XRPs value relative to Ripple, while bulls are buying the dip and arguing that the selloff is an accumulation opportunity.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is in focus around the FDAs decision on ivonescimab for EGFR-mutated lung cancer, a binary approval-or-rejection catalyst. Traders are divided: supporters cite strong progression-free-survival data and a favorable overall-survival trend, while skeptics point to the missed statistical-significance threshold for overall survival; speculation that the share-price decline signals a rejection remains unconfirmed.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is under pressure after its Q3 update and managements cautious comments that analyst expectations for CARVYKTI growth may be at the high end, amid flat U.S. sales and slower earlier-line uptake. Traders debate whether the selloff reflects genuine growth concerns or a sell-the-news overreaction, with some pointing to international growth and upcoming LB2501 in-vivo CAR-T data as potential offsets.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and breakdown through widely watched support levels dominate the discussion, with traders debating whether the decline has further to run or is nearing an oversold bottom. Some cite rising yields, ETF outflows and competition for investment capital as headwinds, while dip buyers see the pullback as an accumulation opportunity.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ioniss earnings-driven selloff is centered on a sharp cut to TRYNGOLZA sales guidance amid slower launch uptake, which overshadowed stronger results elsewhere and pushed shares to new lows. Traders are split between calling the decline an overreaction and viewing weak adoption as a risk, while some cite insider buying as a positive signal.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,719,016.041028 in circulation. The last known price of Algorand is 0.08513994 USD and is down -2.94 over the last 24 hours. It is currently trading on 586 active market(s) with $61,102,468.95 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs slide back toward its long-term lows has sparked a debate between traders warning of further downside and bulls who view the weakness as an accumulation opportunity. Bullish arguments cite Algorands quantum-resistant technology and potential role in tokenization, while bearish posts question adoption, token demand, and whether the networks technology will translate into value for the token.

Aero (AERO) is a cryptocurrency launched in 2023and operates on the Base platform. Aero has a current supply of 2,140,889,212.87723348 with 1,064,756,795.37035192 in circulation. The last known price of Aero is 0.47070254 USD and is down -9.41 over the last 24 hours. It is currently trading on 522 active market(s) with $66,608,274.32 traded over the last 24 hours. More information can be found at https://aero.xyz.

Aerodrome Finance

Discussion centers on the AerodromeVelodrome merger and expansion to additional chains, with traders also highlighting the predictive-allocation upgrade and token buybacks as potential supports. Bulls see broader liquidity and revenue opportunities, while skeptics point to emissions, weak price action, and the risk of a sell-the-news reaction.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

Reports linking an FAA air-traffic-control network outage to systems managed by L3Harris have triggered concern about the companys role and potential liability. Traders are debating whether L3Harris was responsible, with bearish calls and short positions alongside some skepticism and dip-buying interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs quarterly results sparked debate: traders welcomed record revenue growth and a larger backlog, but the wider loss and Neutrons first launch moving to 2027 weighed on sentiment. The successful 100th Electron launch added a bullish counterpoint, with some investors emphasizing execution and long-term demand while others focused on valuation and delays.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,704,555,155.77490568 with 589,238,111,425,239.3151592 in circulation. The last known price of Shiba Inu is 0.00000425 USD and is down -2.37 over the last 24 hours. It is currently trading on 1128 active market(s) with $56,784,935.49 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIB is drawing attention amid weak, largely range-bound price action, with traders posting bearish technical setups and holders voicing frustration over its declines and lack of momentum. Others are buying dips and speculating about a meme-coin rebound, while debate continues over whether token burns and real-world utility can revive demand.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
